We are live on ! Find out more
TPG GP A

TPG GP A Portfolio holdings

AUM $5B Turnover 33.68%
1-Year Est. Return 58.56%
This Fund
S&P 500
This Quarter Est. Return
-6.8%
1 Year Est. Return
+58.56%
3 Year Est. Return
+100.97%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.88B
AUM Growth
-$3.19B
Cap. Flow
-$2.86B
Cap. Flow %
-152.42%
Top 10 Hldgs %
100%
Holding
28
New
–
Increased
1
Reduced
1
Closed
19
Avg Time Held Equity + Options
2.5 years
Top 10 Avg Time Held Equity + Options
0.8 years
Top 20 Avg Time Held Equity + Options
1 year
Avg Time Held Equity only
2.5 years
Top 10 Avg Time Held Equity only
0.8 years
Top 20 Avg Time Held Equity only
1 year

Top Buys

Rank Stock Value
1
SION icon
Sionna Therapeutics
SION
+$786K

Sector Composition

Rank Sector Weight
1 Healthcare 62.48%
2 Consumer Discretionary 34.61%
3 Real Estate 2.92%
4 Energy 0%
5 Communication Services 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
LFST icon
1
Lifestance Health
LFST
$5.11B
$831M 44.29%
160,711,618
– –
2021 Q4
14 quarters
LTH icon
2
Life Time Group Holdings
LTH
$10.7B
$649M 34.61%
21,404,488
-8,344,418
-28% -$248M
2021 Q4
14 quarters
SION icon
3
Sionna Therapeutics
SION
$148M
$117M 6.24%
6,744,962
+60,000
+0.9% +$786K
2025 Q1
1 quarter
AMRX icon
4
Amneal Pharmaceuticals
AMRX
$6.77B
$100M 5.32%
12,328,767
– –
2021 Q4
14 quarters
CBLL icon
5
CeriBell Inc
CBLL
$1.01B
$74.3M 3.96%
3,967,422
– –
2024 Q4
2 quarters
TRTX icon
6
TPG RE Finance Trust
TRTX
$532M
$54.7M 2.92%
7,086,779
– –
2021 Q4
14 quarters
BCAX icon
7
Bicara Therapeutics
BCAX
$542M
$28M 1.49%
3,010,425
– –
2024 Q3
3 quarters
ALLO icon
8
Allogene Therapeutics
ALLO
$377M
$21.1M 1.13%
18,716,306
– –
2021 Q4
14 quarters
RLYB icon
9
Rallybio
RLYB
$84.5M
$1.02M 0.05%
378,552
– –
2021 Q4
14 quarters
AMT icon
10
American Tower
AMT
$90B
– –
-275,589
Closed -$60M –
AMZN icon
11
Amazon
AMZN
$2.81T
– –
-396,110
Closed -$75.4M –
CCC icon
12
CCC Intelligent Solutions
CCC
$4.53B
– –
-7,988,284
Closed -$72.1M –
CMCSA icon
13
Comcast
CMCSA
$88.6B
– –
-1,698,667
Closed -$62.7M –
ENTG icon
14
Entegris
ENTG
$19.1B
– –
-1,193,431
Closed -$104M –
FERG icon
15
Ferguson
FERG
$45.6B
– –
-464,941
Closed -$74.5M –
FWONA icon
16
Liberty Media Corporation Series A Common Stock
FWONA
$25B
– –
-501,606
Closed -$40.9M –
FWONK icon
17
Liberty Media Corporation Series C Common Stock
FWONK
$26.7B
– –
-367,551
Closed -$33.1M –
BRSL icon
18
Brightstar Lottery PLC
BRSL
$1.82B
– –
-2,433,918
Closed -$39.6M –
LNG icon
19
Cheniere Energy
LNG
$57.1B
– –
-496,843
Closed -$115M –
LYV icon
20
Live Nation Entertainment
LYV
$42.2B
– –
-413,744
Closed -$54M –
MCD icon
21
PUT
McDonald's
MCD
$197B
– –
-363,500
Closed -$114M –
MTN icon
22
Vail Resorts
MTN
$5.66B
– –
-718,869
Closed -$115M –
PEGA icon
23
Pegasystems
PEGA
$5.49B
– –
-4,045,466
Closed -$141M –
SHC icon
24
Sotera Health
SHC
$4.53B
– –
-6,786,110
Closed -$79.1M –
UNH icon
25
UnitedHealth
UNH
$355B
– –
-144,948
Closed -$75.9M –

Similar funds

TPG GP A's Q2 2025 Portfolio in Review

As of Q2 2025, TPG GP A held 28 positions worth $1.88B, down 63% from $5.07B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

TPG GP A withdrew a net $2.86B in Q2 2025, closing 19 positions and reducing 1 holding. Its most notable exit was Viking Holdings, an estimated $852M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 62% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Real Estate.

Against the trend, TPG GP A added an estimated $786K to Sionna Therapeutics.

  • TPG GP A added most to Sionna Therapeutics in Q2 2025, an estimated $786K increase.
  • TPG GP A's biggest Q2 2025 reduction was Life Time Group Holdings, cutting an estimated $248M.
  • TPG GP A fully exited Viking Holdings in Q2 2025, selling an estimated $852M.
  • TPG GP A's ten largest holdings make up 100% of its $1.88B portfolio in Q2 2025.
  • TPG GP A opened 0 new positions and closed 19 in Q2 2025.
  • TPG GP A's portfolio value fell 63% quarter-over-quarter to $1.88B.

Based on TPG GP A's 13F filing for Q2 2025, filed 14 Aug 2025.